NO984628D0 - Inhibitor og stimulator av stamcelleproliferasjon og anvendelser derav - Google Patents
Inhibitor og stimulator av stamcelleproliferasjon og anvendelser deravInfo
- Publication number
- NO984628D0 NO984628D0 NO984628A NO984628A NO984628D0 NO 984628 D0 NO984628 D0 NO 984628D0 NO 984628 A NO984628 A NO 984628A NO 984628 A NO984628 A NO 984628A NO 984628 D0 NO984628 D0 NO 984628D0
- Authority
- NO
- Norway
- Prior art keywords
- stem cell
- cell proliferation
- stimulator
- inhibitor
- applications
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/805—Haemoglobins; Myoglobins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Virology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/627,173 US5861483A (en) | 1996-04-03 | 1996-04-03 | Inhibitor of stem cell proliferation and uses thereof |
PCT/US1997/005601 WO1997036922A1 (en) | 1996-04-03 | 1997-04-03 | Inhibitor and stimulator of stem cell proliferation and uses thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
NO984628D0 true NO984628D0 (no) | 1998-10-02 |
NO984628L NO984628L (no) | 1998-12-01 |
NO323610B1 NO323610B1 (no) | 2007-06-18 |
Family
ID=24513524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19984628A NO323610B1 (no) | 1996-04-03 | 1998-10-02 | Polypeptider og peptider som omfatter en hemoglobin-alfa-kjede eller deler derav, farmasoytiske blandinger som omfatter dem, samt anvendelser og fremgangsmater som involverer stamcelleproliferasjonsinhiberende og -stimulerende mengder av polypeptidene og peptidene. |
Country Status (17)
Country | Link |
---|---|
US (4) | US5861483A (no) |
EP (2) | EP1820805A3 (no) |
JP (3) | JP4241927B2 (no) |
KR (1) | KR20040088588A (no) |
CN (2) | CN1264856C (no) |
AT (1) | ATE311406T1 (no) |
AU (1) | AU727023B2 (no) |
CA (1) | CA2249716A1 (no) |
DE (1) | DE69734766T2 (no) |
ES (1) | ES2252781T3 (no) |
HK (1) | HK1069985A1 (no) |
IL (2) | IL126395A0 (no) |
NO (1) | NO323610B1 (no) |
NZ (1) | NZ331895A (no) |
RU (1) | RU2292352C9 (no) |
UA (2) | UA74128C2 (no) |
WO (1) | WO1997036922A1 (no) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5939391A (en) * | 1993-03-31 | 1999-08-17 | Pro-Neuron, Inc. | Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
ES2185649T3 (es) | 1993-03-31 | 2003-05-01 | Wellstat Therapeutics Corp | Inhibidores de la proliferacion de las celulas germinales y sus utilizaciones. |
US6610654B2 (en) * | 1993-03-31 | 2003-08-26 | Wellstat Therapeutics Corporation | Inhibitor of stem cell proliferation and uses thereof |
US5861483A (en) | 1996-04-03 | 1999-01-19 | Pro-Neuron, Inc. | Inhibitor of stem cell proliferation and uses thereof |
AUPO089396A0 (en) * | 1996-07-09 | 1996-08-01 | Howard Florey Institute Of Experimental Physiology And Medicine | Neuroactive peptide |
CA2263978A1 (en) * | 1996-08-27 | 1998-03-05 | Hemosol Inc. | Enhanced stimulation of erythropoiesis |
DE19708454A1 (de) * | 1997-02-17 | 1998-08-27 | Schering Ag | Die Proliferation von Zellen inhibierendes Peptid und dessen Verwendung |
US6620382B1 (en) * | 1998-05-22 | 2003-09-16 | Biopheresis Technologies, Llc. | Method and compositions for treatment of cancers |
US8197430B1 (en) | 1998-05-22 | 2012-06-12 | Biopheresis Technologies, Inc. | Method and system to remove cytokine inhibitor in patients |
US6737051B1 (en) * | 1999-02-03 | 2004-05-18 | I.D.M. Immuno-Designed Molecules | Cell compositions containing macrophages, presenting anti-infectious and hematopoietic properties |
US6379708B1 (en) * | 1999-11-20 | 2002-04-30 | Cytologic, Llc | Method for enhancing immune responses in mammals |
JP2004508412A (ja) | 2000-09-11 | 2004-03-18 | セラプロ テクノロジーズ インコーポレーティッド | 抗新生物薬および免疫刺激薬としてのチオニン |
CA2434672C (en) | 2001-01-10 | 2014-03-25 | Jeffrey S. Rubin | Sfrp and peptide motifs that interact with sfrp and methods of their use |
RU2305107C2 (ru) * | 2001-07-13 | 2007-08-27 | СиЭмЭс ПЕПТАЙДЗ ПЭЙТЕНТ ХОЛДИНГ КОМПАНИ ЛИМИТЕД | Пептид, стимулирующий противоопухолевый иммунный ответ, фармацевтическая композиция на его основе, способ лечения млекопитающего и способ модуляции иммунного ответа |
CN1216072C (zh) * | 2001-07-13 | 2005-08-24 | 一泰医药研究(深圳)有限公司 | 序列号5的生物活性肽 |
DE10141650C1 (de) | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
CA2565215C (en) * | 2004-04-30 | 2014-04-15 | Biopheresis Technologies, Inc. | Method and system to remove soluble tnfr1, tnfr2, and il2 in patients |
FR2872040B1 (fr) * | 2004-06-23 | 2006-09-22 | Centre Nat Rech Scient Cnrse | Utilisation cosmetique d'au moins un tetrapeptide naturel ac-n-ser-asp-lys-pro- ou un de ses analogues en tant qu'agent antivieillissement et restructurant de la peau |
DK1778271T3 (da) * | 2004-08-18 | 2009-02-16 | Ipf Pharmaceuticals Gmbh | Peptid til behandling af herpesvirusinfektioner |
US7850960B2 (en) * | 2004-12-30 | 2010-12-14 | University Of Washington | Methods for regulation of stem cells |
KR100621354B1 (ko) * | 2005-06-14 | 2006-09-08 | 광주과학기술원 | 유비퀴틴을 이용한 아밀로이드-베타 펩티드의 제조방법 |
NZ565394A (en) | 2005-07-26 | 2011-04-29 | Cms Peptides Patent Holding Company Ltd | Biologically active peptides comprising PTTKTYFPHF and their uses for non-therapeutically reducing fatigue |
US20070065514A1 (en) * | 2005-09-22 | 2007-03-22 | Howell Mark D | Method for enhancing immune responses in mammals |
CN1994464B (zh) * | 2005-12-31 | 2010-05-05 | 中国科学院大连化学物理研究所 | 一种血管紧张素i转换酶抑制剂及其应用 |
US20080075690A1 (en) * | 2006-09-22 | 2008-03-27 | Mark Douglas Howell | Method for enhancing immune responses in mammals |
WO2008039874A2 (en) | 2006-09-26 | 2008-04-03 | Cedars-Sinai Medical Center | Cancer stem cell antigen vaccines and methods |
WO2008144019A2 (en) * | 2007-05-18 | 2008-11-27 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Suppression of allergic inflammation by ascaris heme-binding protein (hbp) |
WO2009040023A2 (en) * | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Use of galnon as a therapeutic agent |
US20100216724A1 (en) * | 2007-09-11 | 2010-08-26 | Dorian Bevec | Use of fibronectin fragment (196-203 ) as a therapeutic agent |
WO2009043478A2 (en) * | 2007-09-11 | 2009-04-09 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
ES2342506T3 (es) * | 2008-04-30 | 2010-07-07 | Immatics Biotechnologies Gmbh | Novedosas formulaciones para vacunas de peptidos asociados a tumores, unidos a moleculas del antigeno de leucocito humano (hla) de clase i o ii. |
KR20110092288A (ko) * | 2008-11-07 | 2011-08-17 | 유나이티드 테크놀로지스 유티 에이지 | 인터루킨-1 및 펩티드를 함유하는 조성물 |
US9051548B2 (en) | 2009-02-03 | 2015-06-09 | Children's Medical Center Corporation | Methods for enhancing hematopoietic stem/progenitor cell engraftment |
US9056085B2 (en) | 2009-02-03 | 2015-06-16 | Children's Medical Center Corporation | Methods for enhancing hematopoietic stem/progenitor cell engraftment |
EP2433133A2 (en) * | 2009-05-20 | 2012-03-28 | Universite De Geneve | Mitochondrial activity inhibitors of cancer-initiating cells and use thereof |
US20110070269A1 (en) * | 2009-09-24 | 2011-03-24 | Therapro Technologies, Inc. | Lipopolysaccharide isolated from pyrularia tissue and/or pyrularia-associated bacteria and uses thereof |
RU2452501C2 (ru) * | 2010-08-31 | 2012-06-10 | Александр Владимирович Балюра | Сенситин для эритроцитарного диагностикума для диагностики злокачественных новообразований и способ его получения, эритроцитарный диагностикум для диагностики злокачественных новообразований и способ его получения и способ диагностики наличия злокачественных новообразований с использованием указанного эритроцитарного диагностикума |
WO2012078153A1 (en) * | 2010-12-08 | 2012-06-14 | Viacyte, Inc. | Agents and methods for inhibiting human pluripotent stem cell growth |
WO2012159044A1 (en) * | 2011-05-18 | 2012-11-22 | Wellstat Therapeutics Corporation | Stem cell mobilization and tissue repair and regeneration |
WO2014078787A1 (en) | 2012-11-19 | 2014-05-22 | Wellstat Therapeutics Corporation | Stem cell mobilization and tissue repair and regeneration |
CN103804484B (zh) * | 2014-01-24 | 2016-03-16 | 南京必优康生物技术有限公司 | 一种网红细胞生长因子及其制备方法和应用 |
CN106317177A (zh) * | 2015-06-23 | 2017-01-11 | 首都医科大学 | Gly-Phe-Pro,其合成,活性和应用 |
CN107899001B (zh) * | 2017-05-16 | 2021-08-06 | 陈娟娟 | Notch配体蛋白在制备治疗肿瘤化疗导致骨髓抑制药物方面及早期预后判断方面的应用 |
CN109293737B (zh) * | 2018-09-27 | 2020-10-27 | 华南理工大学 | 一种抗皮肤衰老的四肽及其用途 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1142466A (en) * | 1979-01-09 | 1983-03-08 | Cesar Milstein | Cell lines |
US4683194A (en) * | 1984-05-29 | 1987-07-28 | Cetus Corporation | Method for detection of polymorphic restriction sites and nucleic acid sequences |
US5132213A (en) * | 1986-10-02 | 1992-07-21 | Massachusetts Institute Of Technology | Method for producing proteins and polypeptides using ubiquitin fusions |
US5196321A (en) | 1986-10-02 | 1993-03-23 | Massachusetts Institute Of Technology | Methods for in vitro cleavage of ubiquitin fusion proteins |
US5449759A (en) * | 1987-05-16 | 1995-09-12 | Somatogen, Inc. | Hemoglobins with intersubunit desulfide bonds |
GB8711614D0 (en) * | 1987-05-16 | 1987-06-24 | Medical Res Council | Proteins |
DE69034091T2 (de) * | 1989-05-10 | 2004-04-22 | Baxter Biotech Technology S.A.R.L. | Herstellung von Hämoglobin und Analogen davon in Nicht-Erythrozytzellen |
US5545727A (en) * | 1989-05-10 | 1996-08-13 | Somatogen, Inc. | DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin |
DK0494268T4 (da) * | 1989-09-25 | 1999-11-08 | Genetics Inst | Fremgangsmåde til inhibering af stamcellers vækst |
CA2079229C (en) * | 1990-05-09 | 1999-09-14 | Alexander J. Varshavsky | Ubiquitin-specific protease |
US5239061A (en) * | 1990-06-20 | 1993-08-24 | Research Corporation Technologies, Inc. | Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin |
ATE206760T1 (de) * | 1990-12-20 | 2001-10-15 | Univ Alabama Res Found | Transgenes, vernetztes hämoglobin |
WO1992020369A1 (en) | 1991-05-14 | 1992-11-26 | Dana Farber Cancer Institute | Use of hemoglobin in a method for the treatment of tumors with chemotherapeutic agents |
US5334706A (en) | 1992-01-30 | 1994-08-02 | Baxter International | Administration of low dose hemoglobin to increase perfusion |
EP0655888A4 (en) * | 1992-06-12 | 1997-06-11 | Dnx Corp | PRODUCTION OF HUMAN HEMOGLOBIN IN TRANSGENIC PIGS. |
US5786334A (en) * | 1992-08-14 | 1998-07-28 | Technology Resources International, Inc. | Hexapeptide having immunostimulatory activity |
DE4228458A1 (de) * | 1992-08-27 | 1994-06-01 | Beiersdorf Ag | Multicistronische Expressionseinheiten und deren Verwendung |
US6610654B2 (en) * | 1993-03-31 | 2003-08-26 | Wellstat Therapeutics Corporation | Inhibitor of stem cell proliferation and uses thereof |
US5939391A (en) | 1993-03-31 | 1999-08-17 | Pro-Neuron, Inc. | Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
ES2185649T3 (es) | 1993-03-31 | 2003-05-01 | Wellstat Therapeutics Corp | Inhibidores de la proliferacion de las celulas germinales y sus utilizaciones. |
US5631219A (en) * | 1994-03-08 | 1997-05-20 | Somatogen, Inc. | Method of stimulating hematopoiesis with hemoglobin |
FR2719240B1 (fr) * | 1994-04-29 | 1996-06-07 | Elf Antar France | Procédé de traitement des suspensions huileuses. |
US5861483A (en) * | 1996-04-03 | 1999-01-19 | Pro-Neuron, Inc. | Inhibitor of stem cell proliferation and uses thereof |
US6280739B1 (en) * | 1996-04-18 | 2001-08-28 | Genetics Institute, Inc. | Method of inhibiting angiogenesis using secreted proteins |
-
1996
- 1996-04-03 US US08/627,173 patent/US5861483A/en not_active Expired - Fee Related
-
1997
- 1997-03-04 UA UA98105223A patent/UA74128C2/uk unknown
- 1997-04-03 KR KR10-2004-7014590A patent/KR20040088588A/ko not_active Application Discontinuation
- 1997-04-03 IL IL12639597A patent/IL126395A0/xx not_active IP Right Cessation
- 1997-04-03 EP EP05019956A patent/EP1820805A3/en not_active Withdrawn
- 1997-04-03 AT AT97920117T patent/ATE311406T1/de not_active IP Right Cessation
- 1997-04-03 JP JP53561197A patent/JP4241927B2/ja not_active Expired - Fee Related
- 1997-04-03 CA CA002249716A patent/CA2249716A1/en not_active Abandoned
- 1997-04-03 ES ES97920117T patent/ES2252781T3/es not_active Expired - Lifetime
- 1997-04-03 NZ NZ331895A patent/NZ331895A/xx unknown
- 1997-04-03 CN CNB2004100074707A patent/CN1264856C/zh not_active Expired - Fee Related
- 1997-04-03 RU RU98119712/04A patent/RU2292352C9/ru active
- 1997-04-03 CN CNB971950954A patent/CN1174996C/zh not_active Expired - Fee Related
- 1997-04-03 DE DE69734766T patent/DE69734766T2/de not_active Expired - Lifetime
- 1997-04-03 AU AU24391/97A patent/AU727023B2/en not_active Ceased
- 1997-04-03 US US08/832,443 patent/US6784155B1/en not_active Expired - Fee Related
- 1997-04-03 WO PCT/US1997/005601 patent/WO1997036922A1/en active IP Right Grant
- 1997-04-03 EP EP97920117A patent/EP0891377B1/en not_active Expired - Lifetime
-
1998
- 1998-10-02 NO NO19984628A patent/NO323610B1/no not_active IP Right Cessation
-
2004
- 2004-02-12 US US10/776,172 patent/US7115267B2/en not_active Expired - Fee Related
- 2004-04-06 UA UA20040402942A patent/UA85036C2/ru unknown
-
2005
- 2005-03-30 HK HK05102673A patent/HK1069985A1/xx not_active IP Right Cessation
-
2006
- 2006-03-23 US US11/386,736 patent/US20060166863A1/en not_active Abandoned
- 2006-06-29 IL IL176642A patent/IL176642A0/en unknown
-
2008
- 2008-08-04 JP JP2008201331A patent/JP2009013178A/ja not_active Withdrawn
-
2011
- 2011-10-13 JP JP2011225796A patent/JP2012046537A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO984628L (no) | Inhibitor og stimulator av stamcelleproliferasjon og anvendelser derav | |
DE69431473D1 (de) | Inhibitor der stammzellproliferation und seine verwendung | |
NO971444L (no) | Inhibitor av stamcelle-proliferasjon og anvendelser derav | |
DE3169744D1 (en) | Phosphinylalkanoyl substituted prolines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |